Replimune Group (REPL) Current Ratio
Price: $9.73
Market Cap: $749.35M
Avg Volume: 772.82K
Market Cap: $749.35M
Avg Volume: 772.82K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Replimune Group Current Ratio
- Annual: 10.72
- Quarterly: 11.43
- TTM: 11.43
What is the Current Ratio?
The current ratio is a liquidity ratio that measures a company's ability to pay off its short-term liabilities with its short-term assets. A higher current ratio indicates a greater ability to meet short-term obligations.
Related Metrics
Other important metrics to assess Replimune Group's financial health include:
- Quick Ratio - measures the company's ability to meet short-term obligations with its most liquid assets:
- Annual: 10.72
- Quarterly: 11.43
- TTM: 11.43
- Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
- Annual: 1.84
- Quarterly: 3.60
- TTM: 3.60
These metrics provide insights into Replimune Group's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Current Ratio
10.72
Quarterly Current Ratio
11.43
TTM Current Ratio
11.43
Replimune Group Historical Current Ratio
Historical Quick Ratio
Historical Cash Ratio
Replimune Group Historical Ratios
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Current Ratio | Quick Ratio | Cash Ratio |
|---|---|---|---|
| 2024 | 10.72 | 10.72 | 1.84 |
| 2023 | 17.52 | 17.52 | 4.33 |
| 2022 | 19.46 | 19.46 | 5.10 |
| 2021 | 33.25 | 33.25 | 12.55 |
| 2020 | 14.68 | 14.68 | 5.01 |
| 2019 | 14.26 | 14.26 | 2.60 |
| 2018 | 12.53 | 12.53 | 3.40 |
| 2017 | 11.29 | 11.29 | 10.37 |
Related Metrics
Explore detailed financial metrics and analysis for REPL.